GGrantIndex
Sort

25,944 grants matching neurodegeneration

Changes across the lifespan in the use of heuristics to guide decision-making

$711,784
Michele A Basso · University Of California Los Angeles · R01 · FY2021 · AG

Iron as an Imaging Biomarker for Inflammation in AD

$711,666
Michael M Zeineh · Stanford University · R01 · FY2021 · AG

Hypertension, brain clearance and markers of neurodegeneration

$711,627
Lidia Glodzik · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · NS

Endosome Dysfunction in Alzheimer's Disease

$711,465
Ralph A. Nixon · New York University School Of Medicine · R01 · FY2022 · AG

Frontotemporal Dementias: Genotypes and Phenotypes

$711,440
Virginia M Lee · University Of Pennsylvania · P01 · FY2021 · AG

Eye Determinants of Cognition (EyeDOC) Study

$711,223
Alison G Abraham · Johns Hopkins University · R01 · FY2017 · AG

Pathological mechanisms of white matter hyperintensities

$711,088
Swati Rane Levendovszky · University Of Kansas Medical Center · R01 · FY2025 · AG

Cerebrospinal fluid exchange in Alzheimer's disease characterized by advanced MRI techniques

$710,938
Jiadi Xu · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2023 · AG

Amyloid Beta CAR Macrophages: a cell engineering strategy to clear pathogenic proteins

$710,765
Saar Gill · University Of Pennsylvania · R01 · FY2023 · NS

Image-based cerebrovascular network snythesis(iCNS) to model Alzheimer's Disease

$710,620
Andreas A Linninger · University Of Illinois At Chicago · R01 · FY2024 · AG

Cooperative lead development program for treatment of spinal muscular atrophy

$710,591
Elliot J Androphy · Indiana University Indianapolis · R01 · FY2010 · HD

Brain Bank Core

$710,136
Ann Carolyn McKee · Boston University Medical Campus · U54 · FY2020 · NS

Dissect the mechanisms of selective regional vulnerability in Lewy Body Dementias via comparative snRNA-seq analysis

$710,105
Guoyan Zhao · Washington University · R01 · FY2021 · NS

Time-Resolved MRI Method for EEG Assisted Concurrent Mapping of Cerebral Oxygen Metabolism and Airway Structure in Obstructive Sleep Apnea

$710,082
Felix W Wehrli · University Of Pennsylvania · R01 · FY2024 · HL

Evaluation of Brain and Cognitive Changes in Older Adults with MCI Taking Lithium to Prevent Alzheimer Type Dementia

$709,674
Ariel Gerard Gildengers · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AG

Long-term Neuropsychiatric Sequelae of SARS-CoV-2 Infection in Late Life

$709,599
Amy Lynn Byers · Northern California Institute/Res/Edu · R01 · FY2025 · AG

Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial

$709,313
Kent E Hutchison · University Of Colorado Denver · R01 · FY2024 · AG

Neuroimaging Core

$709,129
John A Detre · University Of Pennsylvania · P30 · FY2021 · AG

Neuroimaging Core

$709,129
John A Detre · University Of Pennsylvania · P30 · FY2022 · AG

Combine computational prediction, network analysis and genetic screening in C elegans to uncover neurodegenerative causes in Alzheimer's Disease

$708,999
Rong Xu · Case Western Reserve University · R01 · FY2022 · AG

Combine computational prediction, network analysis and genetic screening in C elegans to uncover neurodegenerative causes in Alzheimer's Disease

$708,999
Rong Xu · Case Western Reserve University · R01 · FY2021 · AG

The Beaver Dam Offspring Study Neurocognitive Aging Study (BOSS-NCAS)-A Study on the Role of Accelerated Aging and Midlife Sensory Decline for Early Alzheimer’s Disease and Dementia in Later Life

$708,983
Natascha Merten · University Of Wisconsin-Madison · R01 · FY2025 · AG

Cellular senescence, inflammation and neurotransmission in Alzheimer's disease

$708,790
Erin R Hascup · Southern Illinois University Sch Of Med · R01 · FY2018 · AG

Microglial function of GWAS risk factor BIN1 in Alzheimer's disease pathogenesis and inflammatory signaling

$708,640
Gopal Thinakaran · University Of South Florida · R01 · FY2025 · AG

Transcription-associated DNA damage and neurodegeneration

$708,630
Mark J Zylka · Univ Of North Carolina Chapel Hill · R56 · FY2018 · AG